Literature DB >> 7530738

Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection.

S L Tsai1, P J Chen, L H Hwang, J H Kao, J H Huang, T H Chang, D S Chen.   

Abstract

The immune responses to a hepatitis C virus nonstructural protein (T3Ag) overlapping with the C100-3 antigen were examined in three groups of patients with chronic non-A, non-B hepatitis. Group I included 20 cases positive for both anti-C100-3 and the second-generation anti-HCV test (anti-HCV-II): Group II, five cases with anti-C100-3(-)/anti-HCV-II(+); and Group III, seven cases negative for both tests. HCV RNA was detectable in 20 (100%), 4 (80%) and 0 (0%) patients in each group, respectively. Proliferative responses of peripheral blood mononuclear cells to T3Ag were present in 16 (80%), 3 (60%) and 0 (0%) cases in each group, respectively (p < 0.05). Removal of CD8+ T cells from peripheral blood mononuclear cells resulted in a conversion of unresponsiveness to significant proliferation to T3Ag in the remaining cases in groups I and II, but not in group III. This change paralleled the antigen-induced production of interferon-gamma and interleukin-2, but not interleukin-4. The removal also enhanced the T3Ag-stimulated anti-C100-3 antibody production from cultured peripheral blood mononuclear cells in group II patients. These results indicate that the T3Ag-specific type 1 T helper cells play an important role in regulating anti-C100-3 antibody secretion in hepatitis C patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7530738     DOI: 10.1016/s0168-8278(05)80320-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

Review 1.  Immunopathogenesis of viral hepatitis.

Authors:  M U Mondelli
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha.

Authors:  G Piazzolla; C Tortorella; O Schiraldi; S Antonaci
Journal:  J Clin Immunol       Date:  2000-01       Impact factor: 8.317

3.  Comparative features of hepatitis C virus infection in humans and chimpanzees.

Authors:  C M Walker
Journal:  Springer Semin Immunopathol       Date:  1997

4.  Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C.

Authors:  P M Yang; L H Hwang; M Y Lai; W L Huang; Y D Chu; W K Chi; B L Chiang; J H Kao; P J Chen; D S Chen
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

5.  Serotyping of hepatitis C virus in chronic type C hepatitis in Taiwan: correlation with genotypes.

Authors:  J H Kao; H H Lin; P J Chen; M Y Lai; T H Wang; M Mizokami; D S Chen
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

6.  Chronic hepatitis C without anti-hepatitis C antibodies by second-generation assay. A clinicopathologic study and demonstration of the usefulness of a third-generation assay.

Authors:  J H Kao; M Y Lai; Y T Hwang; P M Yang; P J Chen; J C Sheu; T H Wang; H C Hsu; D S Chen
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.